Columvi 10 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FQN6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,701
Award facts
- Contract value 100% obligated
- $20,700.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,700.78 to AmerisourceBergen Drug Corp for Columvi 10 mg/10 mL vials on October 27, 2025, with completion expected by November 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Columvi is a prescription medication used in oncology treatment, reflecting the federal government's ongoing need for specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical prime vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems worldwide. The contractor's consistent award of competitively-awarded delivery orders demonstrates its capability to meet federal procurement requirements for essential pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26FQN6E?
SPE2DR26FQN6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FQN6E worth?
The government has obligated $20,701 on SPE2DR26FQN6E.
Is contract SPE2DR26FQN6E an order under another contract?
Yes. SPE2DR26FQN6E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN6E competed?
The extent of competition for SPE2DR26FQN6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award